Search
Search

SEND Datasets FDA: Enhancing Compliance and Quality in Drug Development

The introduction of the Standard for Exchange of Nonclinical Data (SEND) by the FDA marks a transformative step in drug development. This standardization is designed to streamline the process to collect and present study data submission, ensuring a high level of compliance and quality.